Radius Health (RDUS) Acquired by Gurnet Point Capital and Patient Square Capital for $10/sh Plus CVR of $1/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Results of implant's safety, efficacy and pharmacokinetics for use in various open soft-tissue surgeries expected in first quarter 2022 Innocoll Biotherapeutics plc, a specialty pharmaceutical company
Innocoll Holdings Limited: Anthony Galdi Appointed Chief Commercial Officer of Innocoll
Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced today that Anthony Galdi has been named the Chief Commercial Officer of the Innocoll Group of Companies, effective mid-February. Galdi succeeds Jim Helm, who is retiring and has agreed to assist with the leadership transition.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210204005569/en/
Anthony Galdi (Photo: Business Wire)
Galdi has more than 25 years of experience at Johnson Johnson in the pharmaceutical, consumer and med tech industries, having most recently led the surgical business in the U.S. for Ethicon, Inc., part of Johnson Johnson Medical Device Companies.